Cannabinoids and Terpenes: What Their Test Panels Tell You
Share
Cannabinoid and terpene results often appear on the same laboratory document, but they answer different questions. Reading them as separate panels helps prevent assumptions about what was measured.
Different compounds, different analytical questions
A cannabinoid panel can include separately identified compounds such as CBD, CBDA, delta-9 THC, and THCA. A terpene panel measures its own listed compounds. A result for one group does not establish the composition of the other.
NIST's cannabis measurement program addresses cannabinoids, terpenes, and other analytical targets. Its work emphasizes dependable measurements through methods, reference materials, and laboratory comparisons rather than treating a single headline number as a complete description.
Do not substitute a name for a result
A product name, botanical nickname, or aroma description does not supply measured concentrations. To understand a report, identify the actual compounds, their units, and the sample information associated with them.
Likewise, a cannabinoid total should not be assumed to include terpene measurements. Read the definition of each total instead of adding values from different panels.
Composition is not a personal-effects forecast
A laboratory report can document the compounds its methods measured. By itself, it does not establish how an individual will respond, confirm a treatment benefit, or demonstrate that a material is non-intoxicating.
Keep other testing questions separate
Neither a cannabinoid panel nor a terpene panel replaces pesticide, heavy-metal, microbial, or residual-solvent testing. Those questions require their own appropriate analyses.
A useful reading habit is to write down three things for each panel: what was measured, how it was reported, and which sample it describes. Anything beyond that scope needs additional evidence.
Sources:
